Roxane Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ROXANE
ROXANE has one hundred and twenty-six approved drugs.
There are nine tentative approvals on ROXANE drugs.
Summary for Roxane
| US Patents: | 0 |
| Tradenames: | 74 |
| Ingredients: | 67 |
| NDAs: | 126 |
| Patent Litigation for Roxane: | See patent lawsuits for Roxane |
| PTAB Cases with Roxane as petitioner: | See PTAB cases with Roxane as petitioner |
Drugs and US Patents for Roxane
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roxane | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088663-001 | Mar 15, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Roxane | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 078241-002 | Aug 10, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Roxane | AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride | TABLET;ORAL | 086148-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
